CLINICAL AND PARACLINICAL CHARACTERISTICS AND TREATMENT RESULTS OF COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN AT DA NANG MENTAL HOSPITAL
##plugins.themes.vojs.article.main##
Abstract
Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality in children, especially in developing countries. The overuse and misuse of antibiotics contribute to reduced treatment effectiveness.
Objective: To describe the clinical and paraclinical characteristics and evaluate treatment outcomes of CAP in children at Tam Tri Da Nang General Hospital.
Methods: A cross-sectional descriptive study was conducted on 182 pediatric patients with CAP hospitalized for at least 3 days from March to September 2023.
Results: The majority of patients were aged 1–5 years (63.2%), with 55.5% being male. Common symptoms included cough (100%), fever (71.4%), tachypnea (57.7%), and wheezing (50.5%). Elevated CRP was observed in 83.5% of cases, and leukocytosis in 42.9%. Chest X-ray abnormalities were found in 93.4%, mainly diffuse and lobar infiltrates. A total of 26.9% of children had used antibiotics prior to admission. The most frequently used initial regimens were third-generation cephalosporins (43.6%) and beta-lactam/beta-lactamase inhibitor combinations with macrolides (36.9%). The treatment success rate was 98.9%.
Conclusion: CAP in children presents with diverse clinical and paraclinical features. Empirical antibiotic therapy remains effective when appropriate regimens are selected and clinical monitoring is closely performed.
##plugins.themes.vojs.article.details##
Keywords
Community-acquired pneumonia, children, antibiotic therapy, Tam Tri Da Nang
References
2. Bộ Y tế. Hướng dẫn chẩn đoán và điều trị viêm phổi ở trẻ em. Nhà xuất bản Y học; 2015.
3. World Health Organization. Revised WHO classification and treatment of pneumonia in children at health facilities. Geneva: WHO; 2014.
4. Lê Thị H. Nghiên cứu các yếu tố nguy cơ viêm phổi nặng ở trẻ dưới 5 tuổi. Tạp chí Y học TP. HCM 2020;24(2):45–52.
5. Shi T, McAllister DA, O’Brien KL et al. Global burden of disease due to respiratory syncytial virus. Lancet 2017;390(10098):946–958. [https://doi.org/10.1016/s0140-6736(17)30938-8](https://www.google.com/search?q=https://doi.org/10.1016/s0140-6736(17)30938-8)
6. Bradley JS, Byington CL, Shah SS et al. The management of Community-Acquired Pneumonia in infants and children older than 3 months of age: Clinical practice Guidelines by the Pediatric infectious diseases society and the infectious diseases aociety of America. Clin Infect Dis 2011;53(7):e25-76. [https://doi.org/10.1093/cid/cir531]()
7. Phạm Văn Hưng, Ngô Thị Minh, Nguyễn Thị Hương. Đặc điểm lâm sàng, cận lâm sàng, kết quả điều trị viêm phổi tập trung ở trẻ em từ 2 tháng đến 5 tuổi tại Bệnh viện Nhi Hải Dương năm 2023. Tạp chí Y học Việt Nam 2024;535(1B):333-337. [https://doi.org/10.51298/vmj.v535i1B.8457]()
8. Đào Minh Tuấn và cộng sự. Nghiên cứu gần đây về tác nhân gây bệnh trong viêm phổi cộng đồng trên trẻ em. Tạp chí y học Việt Nam 2013;411:14-20.
9. Phuong TK Nguyen et al. Antibiotic use in children hospitalised with pneumonia in Central Vietnam, Arch Dis Child 2020;0:1-7. [https://doi.org/10.1136/archdischild-2019-317733]()
10. Hecke OV, Bjerrum L, Gentile I et al. Guidance on C-reactive protein point-of-care testing and complementary strategies to improve antibiotic prescribing for adults with lower respiratory tract infections in primary care. Front Med (Lausanne) 2023;30:10:1166742. [https://doi.org/10.3389/fmed.2023.1166742]()